Company Description
Optimer Pharmaceuticals has something for those "oh no, gotta go" moments. The company develops drug candidates for treating a variety of...
Key Optimer Financials
| Company Type | Public - NASDAQ (GM): OPTR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.8 |
| Employees | -- |
More Optimer Financials (8 pages)
Latest Optimer Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Optimer's competition across multiple industries
Top Optimer Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Optimer Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director | Michael N. Chang | Network | E-mail |
| VP CFO, Finance, and Secretary | John D. Prunty | Network | E-mail |
| COO and SVP Corporate Affairs | Tessie M. Che | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Optimer News
- BioWorld Today June 30, 2008 [BioWorld Today] (30 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.